13811-11-5 Usage
Description
3,5-Diiodo-4-hydroxyphenylpropionic acid is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its unique molecular structure, which includes two iodine atoms and a hydroxyl group attached to a phenylpropionic acid backbone. 3,5-diiodo-4-hydroxyphenylpropionic acid plays a significant role in the development of medications targeting specific health conditions.
Uses
Used in Pharmaceutical Industry:
3,5-Diiodo-4-hydroxyphenylpropionic acid is used as an intermediate in the synthesis of 3,3’,5-Triiodo Thyropropionic Acid (T795410), which is a thyroid hormone analog. This hormone analog serves as an antilipemic, helping to regulate lipid levels in the body and potentially treating conditions related to high lipid levels, such as hyperlipidemia.
Additionally, given its role in the synthesis of thyroid hormone analogs, 3,5-diiodo-4-hydroxyphenylpropionic acid may also be utilized in the development of medications for other thyroid-related disorders, such as hypothyroidism or hyperthyroidism. Its specific application would depend on the requirements of the pharmaceutical compound being synthesized and the targeted health condition.
Check Digit Verification of cas no
The CAS Registry Mumber 13811-11-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,8,1 and 1 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13811-11:
(7*1)+(6*3)+(5*8)+(4*1)+(3*1)+(2*1)+(1*1)=75
75 % 10 = 5
So 13811-11-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H8I2O3/c10-6-3-5(1-2-8(12)13)4-7(11)9(6)14/h3-4,14H,1-2H2,(H,12,13)
13811-11-5Relevant articles and documents
CARBONIC ANHYDRASE IX INHIBITOR CONJUGATES AND USES THEREOF
-
Page/Page column 67, (2017/10/13)
The present disclosure relates to compositions and methods of carbonic anhydrase IX inhibitors. The present disclosure also relates to targeting conjugates of carbonic anhydrase IX inhibitors as therapeutics and imaging agents. The present disclosure also relates to the use of targeting conjugates of carbonic anhydrase IX inhibitors in imaging methods and cancer therapy.
N-substituted monomers and polymers
-
Page/Page column 28, (2011/09/19)
Biocompatible, bioresorbable polymers comprising a plurality of monomeric repeating units containing an amide group, wherein said amide groups are N-substituted and the N-substituent and degree of N-substitution are effective to lower the melt viscosity,
Radiopaque polymeric stents
-
Page/Page column 27, (2008/06/13)
Preferred embodiments of the present invention relate to polymeric medical devices, such as stents. More particularly, the polymeric compositions disclosed herein comprise halogen-containing, tyrosine-derived diphenols, optionally in conjunction with othe